The new study, based on 14 different clinical trials, highlights why so many care teams have already adopted the cusp overlap technique when implanting self-expanding TAVR valves.

"These recommendations will help ensure that patient care remains both consistent and personalized," SCAI President Srihari S. Naidu, MD, explained. 

According to Medtronic, its VitalFlow ECMO system was designed and developed with the user experience in mind. 

Has the success of TAVR and other interventional techniques had a negative impact on surgical valve innovation? Two surgeons shared their concerns in a new commentary. 

Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.

Donation after circulatory death heart transplants are gaining popularity in the United States, but men are much more likely to be selected for one. 

The Aventus Thrombectomy System was already cleared to treat blood clots in the peripheral arteries. This latest approval comes after positive results from an IDE study were published in JSCAI.

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.

Even TAVR patients not treated using transfemoral access can typically go home the very next day. 

Patients who put some personality into their symptom descriptions may flummox large language models—to unfortunate effect.

Research into the design and development of AI models for rural healthcare isn’t hard to come by. However, that’s about as far as most of the investigations go.